Cart - OncoTAb

Your cart is currently empty.

Return To Shop

Get Your

Agkura™ Personal Score

Click Here

FDA Approves Kisqali as Initial Endocrine Therapy for Advanced Breast Cancer
The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of […] The post FDA Approves Kisqali as Initial Endocrine Therapy for Advanced Breast Cancer appeared first on .
Aromasin plus Ovarian Suppression Yields Benefit in High-risk Premenopausal Breast Cancer Patients
Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase […] The post Aromasin plus Ovarian Suppression Yields Benefit in High-risk Premenopausal Breast Cancer Patients appeared first on .
U.S. FDA Agrees to Review Talazoparib for Advanced and Triple Negative Breast Cancer for Treatment of Patients with an Inherited BRCA Mutation
The U.S. Food and Drug Administration accepted for filing and granted Priority Review designation for Pfizer’s New Drug Application for […] The post U.S. FDA Agrees to Review Talazoparib for Advanced and Triple Negative Breast Cancer for Treatment of Patients with an Inherited BRCA Mutation appeared first on .
New Study Shows Low-Fat Diet Significantly Reduced Risk of Death After Breast Cancer
By Rowan Chlebowski M.D., Ph.D., a research professor with City of Hope’s Department of Medical Oncology & Therapeutics Research People […] The post New Study Shows Low-Fat Diet Significantly Reduced Risk of Death After Breast Cancer appeared first on .
Ask the Doctor: What is the role of a sentinel lymph node biopsy in breast cancer diagnosis and treatment?
Benjamin O. Anderson, MD Professor of Surgery, University of Washington School of Medicine Q: What is the purpose of lymph […] The post Ask the Doctor: What is the role of a sentinel lymph node biopsy in breast cancer diagnosis and treatment? appeared first on .
Side Effects Not a Major Problem for New CDK Inhibitor Class of Breast Cancer Drugs
CancerConnect News: According to a report published in The Oncologist, cyclin-dependent kinase (CDK) inhibitors, a new class of oral drugs […] The post Side Effects Not a Major Problem for New CDK Inhibitor Class of Breast Cancer Drugs appeared first on .
Comparison of Aromatase Inhibitors Expands Treatment Options for Women Requiring Hormonal Therapy for Early Stage Breast Cancer
CancerConnect News: According to an Italian research team the three aromatase inhibitors approved for the treatment of postmenopausal hormone receptor–positive […] The post Comparison of Aromatase Inhibitors Expands Treatment Options for Women Requiring Hormonal Therapy for Early Stage Breast Cancer appeared first on .
FDA Approves Perjecta for Adjuvant Treatment of HER2-positive Breast Cancer
CancerConnect News: On December 20, 2017, the Food and Drug Administration granted regular approval to Perjeta (pertuzumab) for use in […] The post FDA Approves Perjecta for Adjuvant Treatment of HER2-positive Breast Cancer appeared first on .
At-home Genetic Testing may be Convenient, but it isn’t Complete
March 14, 2018 https://www.statnews.com/2018/03/14/genetic-testing-23andme-brca/ Home delivery for everything from fresh produce to custom-selected clothing has become a way of […] The post At-home Genetic Testing may be Convenient, but it isn’t Complete appeared first on .
FDA Approval for Verzenio™ as Initial Treatment for Advanced Breast Cancer
CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved VerzenioTM (abemaciclib) in combination with an aromatase inhibitor (AI) […] The post FDA Approval for Verzenio™ as Initial Treatment for Advanced Breast Cancer appeared first on .

Get Your

Agkura™ Personal Score

NEWSLETTER

LINKS

ADDRESS

PHONE

EMAIL

Get Your

Agkura™ Personal Score

NEWSLETTER

SOCIAL MEDIA

LINKS

ADDRESS

PHONE

EMAIL